Ahmed Mohammed Abd-Eldayem

Dr. Ahmed Mohammed Abd-Eldayem

Assiut University, Assiut, Egypt
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AAAhmed Mohammed Abd-Eldayem
Ahmed Mohammed Abd-Eldayem
SMSohayla Mahmoud Makram
Sohayla Mahmoud Makram
BMBasim Anwar Shehata Messiha
Basim Anwar Shehata Messiha
HAHanan H. Abd-Elhafeez
Hanan H. Abd-Elhafeez
MAMustafa Ahmed Abdel-Reheim
Mustafa Ahmed Abdel-Reheim
Cyclosporine A (CsA) is employed for organ transplantation and autoimmune disorders. Nephrotoxicity is a serious side effect that hampers the therapeutic use of CsA. Hesperidin and sitagliptin were investigated for their antioxidant, anti-inflammatory, and tissue-protective properties. We aimed to investigate and compare the possible nephroprotective effects of hesperidin and sitagliptin. Male Wistar rats were utilized for induction of CsA nephrotoxicity (20 mg/kg/day, intraperitoneally for 7 days). Animals were treated with sitagliptin (10 mg/kg/day, orally for 14 days) or hesperidin (200 mg/kg/day, orally for 14 days). Blood urea, serum creatinine, albumin, cystatin-C (CYS-C), myeloperoxidase (MPO), and glucose were measured. The renal malondialdehyde (MDA), glutathione (GSH), catalase, and SOD were estimated. Renal TNF-α protein expression was evaluated. Histopathological examination and immunostaining study of Bax, Nrf-2, and NF-κB were performed. Sitagliptin or hesperidin attenuated CsA-mediated elevations of blood urea, serum creatinine, CYS-C, glucose, renal MDA, and MPO, and preserved the serum albumin, renal catalase, SOD, and GSH. They reduced the expressions of TNF-α, Bax, NF-κB, and pathological kidney damage. Nrf2 expression in the kidney was raised. Hesperidin or sitagliptin could protect the kidney against CsA through the mitigation of oxidative stress, apoptosis, and inflammation. Sitagliptin proved to be more beneficial than hesperidin.

31 August 2022 in Molecules
Verified
Journal Article
Open access
PDF file
AAAhmed Mohammed Abd-Eldayem
Ahmed Mohammed Abd-Eldayem
SAsulaiman m Alnasser
sulaiman m Alnasser
HAHanan H. Abd-Elhafeez
Hanan H. Abd-Elhafeez
SSSoha Soliman
Soha Soliman
RARania A. Abdel-Emam
Rania A. Abdel-Emam
The main bioactive constituents in the standardized Ginkgo biloba leaf extract (EGb 761) are the terpene lactones and flavonoid glycosides. EGb 761’s antioxidant and anti-inflammatory properties have previously been demonstrated. Indomethacin-induced gastric ulcers have a multifactorial etiology and represent a major restriction to its therapeutic utility. The underlying ulcerogenic process involves oxidative and inflammatory biomolecular insults. This study was performed to explore the curative and preventative benefits of EGb 761 in experimentally-induced ulcers. To develop gastric ulcers in mice, indomethacin (40 mg/kg) was administered orally. EGb 761 (200 mg/kg) was given by gavage for 7 days before (preventative) and after (therapeutic) indomethacin administration. The histological alterations and macroscopic mucosal lesions were assessed. In gastric tissue homogenates, malondialdehyde (MDA), reduced glutathione (GSH), nitric oxide (NO), and inflammatory cytokines were measured. The expressions of cyclooxygenase-2 (COX-2), cytokines, and proliferating cell nuclear antigen (PCNA) in the stomach mucosa were also investigated. The ulcer index, histological alterations, gastric oxidants, and inflammatory biomarkers were all significantly increased by indomethacin. In stomach specimens, it increased COX-2 and PCNA expression. EGb 761 treatments, both prophylactic and therapeutic, resulted in significant reductions in ulcer lesions, nitrosative and oxidative damage, and inflammatory markers, along with the lowering of COX-2 and PCNA expressions. Furthermore, in the fight against stomach ulcers, EGb 761 treatment was found to be more efficient than prevention.

11 September 2022 in Life Sciences
Verified
Journal Article
Closed access
WAWalied Abdo
Walied Abdo
IHImer Haziri
Imer Haziri
MDMohamed Dmerdash
Mohamed Dmerdash
SAsulaiman m Alnasser
sulaiman m Alnasser
AHAli Hakamy
Ali Hakamy
AAAhmed Mohammed Abd-Eldayem
Ahmed Mohammed Abd-Eldayem

1 January 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
RARania A. Abdel-Emam
Rania A. Abdel-Emam
AAAhmed Mohammed Abd-Eldayem
Ahmed Mohammed Abd-Eldayem

22 June 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
FMFatma Meligy
Fatma Meligy
HMHanan Sharaf El-Deen Mohammed
Hanan Sharaf El-Deen Mohammed
TMTarek M. Mostafa
Tarek M. Mostafa
MEMohamed Elfiky
Mohamed Elfiky
IAIsraa El-Sayed Mohamed Ashry
Israa El-Sayed Mohamed Ashry
SASalwa Fares Ahmed
Salwa Fares Ahmed
This study compared the cardioprotective action of mesenchymal stem cells (MSCs) and PUFAs in a rat model of gentamicin (GM)-induced cardiac degeneration. Male Wistar albino rats were randomized into four groups of eight rats each: group I (control group), group II (gentamicin-treated rats receiving gentamicin intraperitoneally (IP) at dose of 100 mg/kg/day for 10 consecutive days), group III (gentamicin and PUFA group receiving gentamicin IP at dose of 100 mg/kg/day for 10 consecutive days followed by PUFAs at a dose of 100 mg/kg/day for 4 weeks), and group IV (gentamicin and MSC group receiving gentamicin IP at dose of 100 mg/kg/day followed by a single dose of MSCs (1 × 106)/rat IP). Cardiac histopathology was evaluated via light and electron microscopy. Immunohistochemical detection of proliferating cell nuclear antigen (PCNA), caspase-3 (apoptosis), Bcl2, and Bax expression was performed. Moreover, cardiac malonaldehyde (MDA) content, catalase activity, and oxidative stress parameters were biochemically evaluated. Light and electron microscopy showed that both MSCs and PUFAs had ameliorative effects. Their actions were mediated by upregulating PCNA expression, downregulating caspase-3 expression, mitigating cardiac MDA content, catalase activity, and oxidative stress parameters. MSCs and PUFAs had ameliorative effects against gentamicin-induced cardiac degeneration, with MSCs showing higher efficacy compared to PUFAs.

26 April 2024 in European Journal of Pharmacology
Verified
Journal Article
Closed access
MAMarwa A. Ahmed
Marwa A. Ahmed
EKEsam O. Kamel
Esam O. Kamel
AAAhmed Mohammed Abd-Eldayem
Ahmed Mohammed Abd-Eldayem